Dose-dependent pharmacokinetics of benzoic acid following oral administration of sodium benzoate to humans - PubMed (original) (raw)

Clinical Trial

doi: 10.1007/BF00314969.

Affiliations

• PMID: 1804654
• DOI: 10.1007/BF00314969

Clinical Trial

Dose-dependent pharmacokinetics of benzoic acid following oral administration of sodium benzoate to humans

K Kubota et al. Eur J Clin Pharmacol. 1991.

Abstract

Plasma concentration-time data for benzoic and hippuric acids and urinary excretion-time data for hippuric acid were analyzed simultaneously after oral doses of 40, 80 or 160 mg/kg sodium benzoate administered at least one week apart to 6 healthy subjects. The mean AUCs of benzoic acid after the doses of 80 and 160 mg/kg of sodium benzoate were 3.7- and 12.0-times greater, respectively, than after 40 mg/kg. However, the mean AUC of hippuric acid was roughly proportional to the benzoate doses. The observed data were explained by a one-compartment model with first-order rate absorption and Michaelis-Menten elimination of benzoic acid, together with a one-compartment model with first-order elimination for hippuric acid. Although the maximum rate of biotransformation of benzoic acid to hippuric acid varied between 17.2 and 28.8 mg.kg-1.h-1 among the six individuals, the mean value (23.0 mg.kg-1.h-1) was fairly close to that provided by daily maximum dose (0.5 g.kg-1.day-1) recommended in the treatment of hyperammonaemia in patients with inborn errors of ureagenesis. The individual maximum rate of metabolism can be estimated from the urinary excretion rate of hippuric acid 1.5 to 3 h after the single oral dose of 80 to 160 mg.kg-1 sodium benzoate. The justification of this concept requires further studies in patients with inborn errors of urea synthesis.

PubMed Disclaimer

Similar articles

• Determination of benzoic acid and hippuric acid in human plasma and urine by high-performance liquid chromatography.
  Kubota K, Horai Y, Kushida K, Ishizaki T. Kubota K, et al. J Chromatogr. 1988 Mar 4;425(1):67-75. doi: 10.1016/0378-4347(88)80007-0. J Chromatogr. 1988. PMID: 3360879
• Evaluation of liver function by co-administration methodology using 13C-labelled benzoic acid and hippuric acid coupled with nuclear magnetic resonance spectroscopy.
  Akira K, Negishi E, Yamamoto C, Baba S. Akira K, et al. J Pharm Pharmacol. 1997 Dec;49(12):1242-7. doi: 10.1111/j.2042-7158.1997.tb06078.x. J Pharm Pharmacol. 1997. PMID: 9466351
• Excretion of hippuric acid during sodium benzoate therapy in patients with hyperglycinaemia or hyperammonaemia.
  Barshop BA, Breuer J, Holm J, Leslie J, Nyhan WL. Barshop BA, et al. J Inherit Metab Dis. 1989;12(1):72-9. doi: 10.1007/BF01805533. J Inherit Metab Dis. 1989. PMID: 2501586
• [Rationale for the use of sodium benzoate in clinical hepatology].
  Poo JL, Cervera E, de Hoyos A, Gil S, Cadena M, Uribe M. Poo JL, et al. Rev Invest Clin. 1990 Jul;42 Suppl:101-5. Rev Invest Clin. 1990. PMID: 19256146 Review. Spanish.
• The biochemistry and toxicology of benzoic acid metabolism and its relationship to the elimination of waste nitrogen.
  Tremblay GC, Qureshi IA. Tremblay GC, et al. Pharmacol Ther. 1993 Oct;60(1):63-90. doi: 10.1016/0163-7258(93)90022-6. Pharmacol Ther. 1993. PMID: 8127924 Review.

Cited by

• Mapping of the benzoate metabolism by human gut microbiome indicates food-derived metagenome evolution.
  Yadav M, Lomash A, Kapoor S, Pandey R, Chauhan NS. Yadav M, et al. Sci Rep. 2021 Mar 10;11(1):5561. doi: 10.1038/s41598-021-84964-6. Sci Rep. 2021. PMID: 33692426 Free PMC article.
• Impact of concerning excipients on animal safety: insights for veterinary pharmacotherapy and regulatory considerations.
  Thomazini VC, da Cunha GM, Guimarães NM, Saleme SD, de Melo RCG, de Paula GA, Carvalho SG, Chorilli M, Dos Santos Giuberti C, Villanova JCO. Thomazini VC, et al. Daru. 2024 Jun;32(1):289-305. doi: 10.1007/s40199-023-00486-8. Epub 2023 Oct 31. Daru. 2024. PMID: 37903944 Free PMC article. Review.
• Metabolite profiles during oral glucose challenge.
  Ho JE, Larson MG, Vasan RS, Ghorbani A, Cheng S, Rhee EP, Florez JC, Clish CB, Gerszten RE, Wang TJ. Ho JE, et al. Diabetes. 2013 Aug;62(8):2689-98. doi: 10.2337/db12-0754. Epub 2013 Feb 4. Diabetes. 2013. PMID: 23382451 Free PMC article.
• Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity.
  Shaham O, Wei R, Wang TJ, Ricciardi C, Lewis GD, Vasan RS, Carr SA, Thadhani R, Gerszten RE, Mootha VK. Shaham O, et al. Mol Syst Biol. 2008;4:214. doi: 10.1038/msb.2008.50. Epub 2008 Aug 5. Mol Syst Biol. 2008. PMID: 18682704 Free PMC article.

References

1. 1. J Chromatogr. 1988 Mar 4;425(1):67-75 - PubMed
2. 1. Biochem J. 1951 Jan;48(1):88-96 - PubMed
3. 1. N Engl J Med. 1972 Aug 31;287(9):430-2 - PubMed
4. 1. Arch Biochem Biophys. 1989 Feb 15;269(1):201-7 - PubMed
5. 1. J Pediatr. 1987 Apr;110(4):634-6 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Other Literature Sources

  • The Lens - Patent Citations Database